Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Briefing Explores Associations between Air Pollution and Health Outcomes

Published: Monday, February 25, 2013
Last Updated: Monday, February 25, 2013
Bookmark and Share
Health risks associated with high levels of air pollution may vary between neighborhoods across large urban populations.

Lance Waller, PhD, chair of Biostatistics and Bioinformatics at Emory's Rollins School of Public Health, will present preliminary work that explores relationships between high-levels of air pollution exposure and health effects at a press briefing hosted by the American Association for the Advancement of Science on February 17, at 2 p.m. EST, in Boston.

During the briefing, Waller will summarize his joint work with the Southeastern Center for Air Pollution Epidemiology (SCAPE), funded by the Environmental Protection Agency.  SCAPE tests air pollution levels in various areas of Metro Atlanta and their health effects, based on data from associated emergency room visits, in order to determine relationships to exposure. Waller's research will assess the general findings of SCAPE to identify spatial uncertainties in exposures.

"SCAPE has identified geographically-referenced air pollution levels and health outcomes," explains Waller.  "Our work will analyze these data to determine whether the effects seen city-wide mirror those observed in local neighborhoods."

The team will also identify communities with higher risk levels and examine potential roles of behavioral connections such as prolonged outdoor activity and socio-economic status.

Satellite data –data collected by measuring light—will be collected to determine air pollution levels in areas where ground monitors—data collected by filters-- are not located.  Assessments made on the associations between monitored levels and satellite levels will help observe relationships over a broader region.

A second part of the research looks at pollution levels and the association specifically with respiratory diseases, as certain communities show stronger associations with these outcomes.  Waller hopes that his research will lead to improved understanding of the causes of these outcomes.

"Each component of our research is essential because it generates potential solutions," says Waller.  "If we can identify areas that are healthier, we may be able to identify why they are healthier and use these solutions as models to implement in other communities."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanoparticles Deliver Anticancer Cluster Bombs
Researchers at Emory have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.
Saturday, April 16, 2016
Mixed-Strain Malaria Influences Drug Resistance
Scientists have documented for the first time how competition among different malaria parasite strains in human hosts could influence the spread of drug resistance.
Thursday, March 24, 2016
DTRA Awards $9.7M Contract for Drug Development
The Defense Threat Reduction Agency (DTRA) has awarded Emory University a $9.7M contract to develop drugs to treat infections caused by emerging and man-made viral threats. Under the contract, the DTRA funds will be used to advance the development of the lead drug candidate.
Thursday, February 04, 2016
Predicting Flu Vaccine Efficacy
Researchers reveal novel molecular signatures that could be used to predict which individuals are most likely to respond positively to vaccination.
Thursday, December 17, 2015
How White Blood Cells Limit Muscle Regeneration
Researchers have identified a protein produced by white blood cells that puts the brakes on muscle repair after injury.
Monday, August 10, 2015
First Look At Hospitalized Ebola Survivors' Immune Cells Could Guide Vaccine Design
Emory and CDC researchers have been examining immune cells obtained from four patients treated at Emory University Hospital in 2014.
Wednesday, March 11, 2015
One-minute Point-of-Care Anemia Test Shows Promise in New Study
Test produces results in about 60 seconds and requires no electrical power.
Tuesday, September 16, 2014
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Tuesday, September 16, 2014
Quality Control Guidelines Proposed for Genomics Studies
Guidelines for researchers studying the effects of rare genetic variants.
Friday, April 25, 2014
Steering Stem Cells with Magnets
Magnets could be a tool for directing stem cells’ healing powers to treat conditions such as heart disease or vascular disease.
Thursday, July 18, 2013
X-ray Research at Diamond Paves Way for Lassa Fever Vaccine and Drug Development
Research shows how the Lassa virus remains invisible to the human defence system and causes thousands of deaths each year.
Friday, November 19, 2010
Emory Study Yields Clue to How Stem Cells Form
Study shows some of the first direct evidence of a process required for epigenetic reprogramming between generations.
Tuesday, April 21, 2009
Researchers Discover Strategy for Predicting the Immunity of Vaccines
Emory study reveals how a highly successful vaccine triggers robust immune responses.
Monday, November 24, 2008
NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Emory University's School of Medicine has received a $3.6M grant form NIH to study a human genetic variation linked to schizophrenia.
Tuesday, May 22, 2007
Scientists Determine How Tumor Gene Controls Growth
Researchers have uncovered details about how Tsg 101 Gene causes cells to overgrow.
Monday, November 07, 2005
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!